* Heartbeam Inc BEAT.OQ reported a quarterly adjusted loss
of 15
cents per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -45
cents. The mean expectation of four analysts for the quarter
was for a loss of 13 cents per share. Wall Street expected
results to range from -14 cents to -12 cents per share.
* Reported revenue was zero; analysts expected $41.67
thousand.
* Heartbeam Inc's reported EPS for the quarter was a loss
of 15
cents.
* The company reported a quarterly loss of $3.88 million.
* Heartbeam Inc shares had fallen by 1.7% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Heartbeam Inc is
$5.78
This summary was machine generated from LSEG data March 20 at
09:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.13 -0.15 Missed
Sep. 30 2023 -0.13 -0.13 Met
Jun. 30 2023 -0.23 -0.16 Beat
Mar. 31 2023 -0.31 -0.50 Missed